Aptamers, a New Therapeutic Opportunity for the Treatment of Multiple Myeloma

SIMPLE SUMMARY: Multiple Myeloma (MM) remains incurable due to high relapse rates and fast development of drug resistances. Monoclonal antibodies (mAb) have revolutionized MM treatment, opening the door to chemotherapy-free yet curative treatments. Nevertheless, antibody-based therapies face several...

Descripción completa

Detalles Bibliográficos
Autores principales: Amundarain, Ane, Pastor, Fernando, Prósper, Felipe, Agirre, Xabier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657029/
https://www.ncbi.nlm.nih.gov/pubmed/36358889
http://dx.doi.org/10.3390/cancers14215471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657029/
https://www.ncbi.nlm.nih.gov/pubmed/36358889
http://dx.doi.org/10.3390/cancers14215471

Ejemplares similares